State-Owned Drugs Giant Seeks New Owner

Serbia won’t make big money by selling off debt-ridden state pharmaceuticals company Galenika, but it will offload a big problem.

Stevan Veljovic

BIRN

Belgrade

Subscribe to Balkan Insight Premium to read the full article.

Please login to your account below if you are already a Premium Subscriber.

Login

Username:

Password:

Buy Premium Subscription

Our Premium Service gives you full access to all content published on BalkanInsight.com, including analyses, investigations, comments, interviews and more. Choose your subscription today and get unparalleled in-depth coverage of the Western Balkans.

Premium Selection

With three new institutions finally established to vet Albania’s future judges and prosecutors, judicial reform looked promising. However, observers worry a lack of transparency will erode public trust in the process.